---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-022465"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:54:11.214602+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD signs merger agreement with Athene Parent for cash tender offer and merger

## Summary
- Merger Agreement dated May 27, 2022 with Athene Parent, Inc. and Athene Merger Sub, Inc.
- Cash tender offer to acquire all outstanding TXMD common shares, followed by a merger.
- Board amended bylaws to exempt the transaction from Nevada's control share acquisition statute.
- No deal price, premium, or expected closing date disclosed in this filing.

## SEC filing metadata
- accession: 0001564590-22-022465
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/0001564590-22-022465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/txmd-8k_20220527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-022465
- JSON: https://secwatch.observer/filing/0001564590-22-022465.json
- Plain text: https://secwatch.observer/filing/0001564590-22-022465.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.